Gates Foundation, Wellcome, Mastercard Fund COVID-19 Clinical Trials
Muhammad Irfan Published March 31, 2020 | 06:45 PM
SEATTLE, (UrduPoint / Pakistan Point News / WAM - 31st Mar, 2020) Researchers at three institutions in the US and UK have received grants to advance studies of repurposed drugs and novel antibodies in a bid to combat COVID-19.
Partners in the COVID-19 Therapeutics Accelerator - Bill and Melinda Gates Foundation, Wellcome, and Mastercard - announced on Tuesday grants of US$20 million to three institutions to fund clinical trials to identify "highly potent immunotherapies" for the COVID-19 pandemic. The grant recipients are the University of Washington, University of Oxford and La Jolla Institute for Immunology.
Currently, there are no broad-spectrum antivirals or immunotherapies available to prevent or treat COVID-19.
Two of the newly announced trials will fund an investigation of two well-established drugs, hydroxychloroquine and chloroquine, that have known antiviral properties.
These drugs have been used to treat malaria and a variety of rheumatological conditions for more than 50 years.
While these two drugs have shown promise in early studies to treat COVID-19 patients, a need for large, randomised controlled trials are still needed to determine effectiveness.
Gates Foundation CEO Mark Suzman noted that the grants will advance the understanding of how existing drugs and antibodies can contribute to addressing the pandemic.
The initial investments via the accelerator will bring "rigor" to the study of potential solutions, allowing for a way forward through "sound science and shared data," he added.
Multiple trial testing methods were noted in a statement by the Gates Foundation.
First of which will be a multi-cite clinical trial conducted by the University of Washington in Western Washington and the New York City Area. The trial will enrol up to 2,000 asymptomatic men and women who are close contacts of persons with confirmed or pending COVID-19 diagnoses.
Held in cooperation with the New York University's school of Medicine, the drug trial will investigate whether hydroxychloroquine can effectively prevent COVID-19 in people already exposed to the infection.
The Mahidol Oxford Tropical Medicine Research Unit, MORU, will also lead a placebo-controlled prophylaxis study of chloroquine and hydroxychloroquine in preventing COVID-19 in at-risk health care workers, frontline staff, and other high-risk groups.
At least 40,000 participants in Asia and Europe will be randomised to receive either chloroquine (East Asian countries), hydroxychloroquine (United Kingdom and Europe), or a matched film-coated placebo as daily prophylaxis for three months.
The Gates Foundation noted that both drug trials will begin participant enrolment in April, with results of the trials available in late 2020.
In addition to funding drug trials, the accelerator will provide $1.73 million to the La Jolla Institute for Immunology to establish a Coronavirus Immunotherapy Consortium, known as CoVIC. The effort will bring together scientists from around the world and enable them to share and evaluate candidate antibodies side by side in a blinded, multidisciplinary analysis to identify ideal therapeutic combinations.
Related Topics
Recent Stories
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 26 April 2024
Today Gold Rate in Pakistan 26 April 2024
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
More Stories From Middle East
-
UAE announces ‘Zero Bureaucracy Program’ to reduce bureaucracy
3 months ago -
COP28 President-Designate welcomes Transitional Committee agreement to operationalise Loss and Damag ..
6 months ago -
Global Media Congress 2023 to feature Co-Production Majlis as a new networking platform
6 months ago -
Young female athletes shine at Abu Dhabi World Youth Jiu-Jitsu Championship
6 months ago -
King of Jordan receives Abdullah bin Zayed and ministers participating in Arab coordination meeting
6 months ago -
Abdullah bin Zayed participates in coordination meeting of Arab foreign ministers, joint meeting wit ..
6 months ago
-
3rd annual conference of Emirates Society of Clinical Microbiology kicks off in Dubai
6 months ago -
SIBF 2023 hosts Nobel laureate to discuss emergence of ‘Afrofuturism’ in global discourse
6 months ago -
ALC announces winners of Kanz Al Jeel Award 2023
6 months ago -
SIBF turns spotlight on remarkable contributions of women
6 months ago -
Global assets in spot bitcoin ETFs hit $4.16 billion
6 months ago -
Rescuers struggle to find Nepal quake survivors as deaths reach 157
6 months ago